Literature DB >> 2216464

Human TRK proto-oncogene maps to chromosome 1q32-q41.

M Miozzo1, M A Pierotti, G Sozzi, P Radice, I Bongarzone, N K Spurr, G Della Porta.   

Abstract

The chromosomal localization of TRK, a gene coding for a putative receptor molecule with an associated tyrosine kinase activity that we have found activated in 25% of patients with papillary thyroid carcinoma, was determined by Southern blot analysis of a panel of human-rodent somatic cells using a cDNA clone containing the entire human TRK proto-oncogene (Martin-Zanca et al., 1986). The TRK gene was assigned to chromosome 1. One hybrid that had retained only the short arm of the human chromosome 1 was negative. Subsequently, in situ hybridization of the same probe to human metaphase chromosomes localized the TRK gene to 1q32-q41.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216464

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.

Authors:  Annalisa Pezzolo; Elena Rossi; Stefania Gimelli; Federica Parodi; Francesca Negri; Massimo Conte; Angela Pistorio; Angela Sementa; Vito Pistoia; Orsetta Zuffardi; Claudio Gambini
Journal:  Neuro Oncol       Date:  2008-10-15       Impact factor: 12.300

Review 2.  Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.

Authors:  M A Pierotti; I Bongarzone; M G Borrello; C Mariani; C Miranda; G Sozzi; A Greco
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

3.  Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor.

Authors:  S Mardy; Y Miura; F Endo; I Matsuda; L Sztriha; P Frossard; A Moosa; E A Ismail; A Macaya; G Andria; E Toscano; W Gibson; G E Graham; Y Indo
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

4.  Recurrent genetic aberrations in thymoma and thymic carcinoma.

Authors:  A Zettl; P Ströbel; K Wagner; T Katzenberger; G Ott; A Rosenwald; K Peters; A Krein; M Semik; H K Müller-Hermelink; A Marx
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Clinical significance of NTRK family gene expression in neuroblastomas.

Authors:  Jennifer E Light; Hiroshi Koyama; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Jennifer L Mangino; Venkatadri Kolla; Wendy B London; Garrett M Brodeur
Journal:  Pediatr Blood Cancer       Date:  2011-10-11       Impact factor: 3.167

6.  A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse.

Authors:  Kiyoshi Kano; C Marín de Evsikova; James Young; Christopher Wnek; Terry P Maddatu; Patsy M Nishina; Jürgen K Naggert
Journal:  Mol Endocrinol       Date:  2008-05-15

7.  Chromosome mapping of nine tropomyosin-related sequences in mice.

Authors:  M Gariboldi; G Manenti; T A Dragani; M A Pierotti
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

8.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.

Authors:  G A Rodrigues; M Park
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

Review 9.  Genetics and epigenetics of sporadic thyroid cancer.

Authors:  Dang Vu-Phan; Ronald J Koenig
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

10.  The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.

Authors:  A Greco; C Mariani; C Miranda; A Lupas; S Pagliardini; M Pomati; M A Pierotti
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.